JP2008511634A5 - - Google Patents

Download PDF

Info

Publication number
JP2008511634A5
JP2008511634A5 JP2007530141A JP2007530141A JP2008511634A5 JP 2008511634 A5 JP2008511634 A5 JP 2008511634A5 JP 2007530141 A JP2007530141 A JP 2007530141A JP 2007530141 A JP2007530141 A JP 2007530141A JP 2008511634 A5 JP2008511634 A5 JP 2008511634A5
Authority
JP
Japan
Prior art keywords
galactosylceramide
alkene
glycosylceramide
group
alkane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007530141A
Other languages
English (en)
Japanese (ja)
Other versions
JP5226311B2 (ja
JP2008511634A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/030330 external-priority patent/WO2006026389A2/en
Publication of JP2008511634A publication Critical patent/JP2008511634A/ja
Publication of JP2008511634A5 publication Critical patent/JP2008511634A5/ja
Application granted granted Critical
Publication of JP5226311B2 publication Critical patent/JP5226311B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007530141A 2004-08-27 2005-08-26 免疫及び自己免疫の調節因子としてのセラミド誘導体 Expired - Fee Related JP5226311B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60536204P 2004-08-27 2004-08-27
US60/605,362 2004-08-27
PCT/US2005/030330 WO2006026389A2 (en) 2004-08-27 2005-08-26 Ceramide derivatives as modulators of immunity and autoimmunity

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012152661A Division JP2012211182A (ja) 2004-08-27 2012-07-06 免疫及び自己免疫の調節因子としてのセラミド誘導体

Publications (3)

Publication Number Publication Date
JP2008511634A JP2008511634A (ja) 2008-04-17
JP2008511634A5 true JP2008511634A5 (enExample) 2008-10-16
JP5226311B2 JP5226311B2 (ja) 2013-07-03

Family

ID=36000590

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2007530141A Expired - Fee Related JP5226311B2 (ja) 2004-08-27 2005-08-26 免疫及び自己免疫の調節因子としてのセラミド誘導体
JP2012152661A Withdrawn JP2012211182A (ja) 2004-08-27 2012-07-06 免疫及び自己免疫の調節因子としてのセラミド誘導体
JP2014185949A Expired - Fee Related JP5870327B2 (ja) 2004-08-27 2014-09-12 免疫及び自己免疫の調節因子としてのセラミド誘導体

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2012152661A Withdrawn JP2012211182A (ja) 2004-08-27 2012-07-06 免疫及び自己免疫の調節因子としてのセラミド誘導体
JP2014185949A Expired - Fee Related JP5870327B2 (ja) 2004-08-27 2014-09-12 免疫及び自己免疫の調節因子としてのセラミド誘導体

Country Status (10)

Country Link
US (1) US7772380B2 (enExample)
EP (1) EP1784196B1 (enExample)
JP (3) JP5226311B2 (enExample)
KR (2) KR101377116B1 (enExample)
CN (1) CN101010086B (enExample)
AU (1) AU2005280163B2 (enExample)
CA (1) CA2577009C (enExample)
IL (1) IL181054A (enExample)
NZ (1) NZ553320A (enExample)
WO (1) WO2006026389A2 (enExample)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9809654B2 (en) 2002-09-27 2017-11-07 Vaccinex, Inc. Targeted CD1d molecules
US7645873B2 (en) 2003-03-20 2010-01-12 The Scripps Research Institute 6″-amino-6″-deoxygalactosylceramides
US8022043B2 (en) * 2004-08-27 2011-09-20 Albert Einstein College Of Medicine Of Yeshiva University Ceramide derivatives as modulators of immunity and autoimmunity
EP1784196B1 (en) * 2004-08-27 2016-12-21 Albert Einstein College Of Medicine Of Yeshiva University Ceramide derivatives as modulators of immunity and autoimmunity
GB0419846D0 (en) 2004-09-07 2004-10-13 Chiron Srl Vaccine adjuvants for saccharides
US7534434B2 (en) 2004-12-28 2009-05-19 The Rockefeller University Glycolipids and analogues thereof as antigens for NK T cells
US7923013B2 (en) 2004-12-28 2011-04-12 The Rockefeller University Glycolipids and analogues thereof as antigens for NKT cells
US20100129339A1 (en) * 2005-10-06 2010-05-27 Riken Nkt cell-stimulating agent for administration through upper respiratory tract mucous membrane
GB0605247D0 (en) * 2006-03-15 2006-04-26 Chiron Srl Compositions and methods for immunisation
BRPI0710668A2 (pt) 2006-04-07 2011-08-16 Scripps Res Insittute alfa-galactosil ceramidas modificadas para marcar e estimular células t matadoras naturais
CA2655947C (en) 2006-06-30 2016-08-02 The Scripps Research Institute Compositions comprising nkt cell agonist compounds and methods of use
JP2010504332A (ja) * 2006-09-19 2010-02-12 ヒューマン バイオモレキュラル リサーチ インスティテュート アルツハイマー病の診断方法及び遺伝子マーカー
WO2008047174A1 (en) * 2006-10-18 2008-04-24 Centre National De La Recherche Scientifique Alpha-galactosylceramide analogs, their methods of manufacture, intermediate compounds useful in these methods, and pharmaceutical compositions containing them
KR100868959B1 (ko) * 2006-12-30 2008-11-17 재단법인서울대학교산학협력재단 알파-갈락토실세라마이드 유도체, 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는면역보조용 약학적 조성물
WO2008103392A2 (en) * 2007-02-21 2008-08-28 Vaccinex, Inc. Modulation of nkt cell activity with antigen-loaded cdid molecules
JP2010519274A (ja) 2007-02-21 2010-06-03 フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー（ヴェーイーベー・ヴェーゼットウェー） ＴＮＦおよびα−ガラクトシルセラミドを使用する併用療法
CA2685125A1 (en) * 2007-04-25 2008-11-06 Immurx, Inc. Adjuvant combinations comprising an nkt activator, a cd40 agonist, and optionally an antigen and use thereof for inducing a synergistic enhancement in cellular immunity
US8916164B2 (en) * 2007-08-29 2014-12-23 Abivax Methods of enhancing adjuvaticity of vaccine compositions
CA2702344C (en) 2007-10-12 2016-09-27 Luigi Panza Analogues of glycolipids useful as immunoadjuvants
EP2058011A1 (en) 2007-11-07 2009-05-13 Wittycell Nkt cell activating gycolipids covalently bound antigens and/or drug
US7928077B2 (en) * 2008-07-11 2011-04-19 Academia Sinica Alpha-galactosyl ceramide analogs and their use as immunotherapies
WO2010027479A2 (en) 2008-09-08 2010-03-11 Children's Medical Center Corporation Mucosal delivery of therapeutic molecules, proteins, or particles coupled to ceramide lipids
JP5574432B2 (ja) * 2008-09-11 2014-08-20 独立行政法人理化学研究所 エステル化α−ガラクトシルセラミド類
JP5809560B2 (ja) 2008-10-08 2015-11-11 アビヴァックス インフルエンザに対して使用するためのワクチン組成物
EP2385980B1 (en) * 2009-01-08 2018-04-18 Albert Einstein College of Medicine, Inc. Bacterial vaccines with cell wall-associated ceramide-like glycolipids and uses thereof
KR20110045545A (ko) * 2009-10-27 2011-05-04 서울대학교산학협력단 신규 알파-갈락토실세라마이드 유도체, 이의 약학적으로 허용 가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 면역보조용 약학적 조성물
US8835613B2 (en) * 2010-03-12 2014-09-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services β-mannosylceramide and stimulation of NKT cell anti-tumor immunity
WO2013007792A1 (en) * 2011-07-14 2013-01-17 Thurgauische Stiftung Für Wissenschaft Und Forschung Novel th2 polarizing compounds
EP2755688A4 (en) 2011-10-27 2014-08-06 Nkt Therapeutics Inc HUMANIZED ANTIBODIES AGAINST INKT
EP2785353A4 (en) * 2011-11-28 2015-06-17 Uti Limited Partnership PROPHYLACTIC COMPOSITIONS FOR THE MANAGEMENT OF MICROBIAL INFECTIONS IN PATIENTS WITH CEREBRAL INJURY
US10227290B2 (en) 2012-02-07 2019-03-12 The Regents Of The University Of California Glycosphingolipids for use in modulating immune responses
KR101969814B1 (ko) * 2012-02-24 2019-04-18 주식회사 진영바이오 글리코실 세라마이드 화합물 및 그 제조방법
AU2013237497B2 (en) * 2012-03-19 2016-05-12 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Carbohydrate-glycolipid conjugate vaccines
US9708601B2 (en) 2012-04-26 2017-07-18 Vaccinex, Inc. Fusion proteins to facilitate selection of cells infected with specific immunoglobulin gene recombinant vaccinia virus
KR102099764B1 (ko) * 2012-04-26 2020-04-10 리가가쿠 겐큐쇼 신규 카르바메이트 당지질 및 그 용도
KR102162619B1 (ko) * 2012-07-26 2020-10-08 빅토리아 링크 엘티디 유기 화합물
US20150224129A1 (en) 2012-10-03 2015-08-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza with invariant nkt cell agonists
CA2925878A1 (en) 2012-10-12 2014-04-17 The Brigham And Women's Hospital, Inc. Glycosphingolipids and methods of use thereof
US9861702B2 (en) 2012-10-22 2018-01-09 Wisconsin Alumni Research Foundation Lipid-conjugated rhamnose for immune system recruitment and oncotherapy
CA2893918C (en) * 2012-12-06 2020-11-24 Callaghan Innovation Research Limited Conjugate compounds
US9371352B2 (en) 2013-02-08 2016-06-21 Vaccinex, Inc. Modified glycolipids and methods of making and using the same
CN105339379B (zh) * 2013-02-08 2019-11-26 瓦克纳斯有限公司 改性的糖脂及其制备和使用方法
CN105247068A (zh) * 2013-03-15 2016-01-13 珀金埃尔默健康科学股份有限公司 与溶酶体贮积症的测试相关的化合物和方法
CN105682666B (zh) * 2013-09-06 2021-06-01 中央研究院 使用醣脂激活人类iNKT细胞
CN105461681A (zh) * 2014-09-05 2016-04-06 中国科学院生态环境研究中心 具有抗肿瘤活性的krn7000类似物及合成方法
TWI745275B (zh) * 2014-09-08 2021-11-11 中央研究院 使用醣脂激活人類ｉＮＫＴ細胞
KR101589633B1 (ko) * 2014-09-18 2016-02-01 한국과학기술연구원 당세라마이드 유도체 및 이의 제조방법
CN104497065B (zh) * 2014-11-24 2017-10-24 浙江大学 α‑半乳糖神经酰胺新异构体及其用途
CN104497064B (zh) * 2014-11-24 2017-10-24 浙江大学 α‑半乳糖神经酰胺新异构体及其合成方法
CN105384785B (zh) * 2015-11-24 2018-06-19 中国人民解放军第二军医大学 含有半乳糖类脂肪酸衍生物的制备方法及其在医药领域的应用
PT3445397T (pt) 2016-04-22 2023-01-13 Vaccinex Inc Exibição de proteína integral de membrana sobre viriões envelopados extracelulares de poxvírus
WO2017207040A1 (en) 2016-06-01 2017-12-07 Vib Vzw ANTI-CANCER THERAPY USING A LEPTIN ANTAGONIST AND AN iNKT-CELL ACTIVATOR
IL264343B2 (en) 2016-08-02 2024-05-01 Vaccinex Inc Improved methods for producing polynucleotide libraries in vaccinia virus/eukaryotic cells
AU2018354422A1 (en) 2017-10-27 2020-05-28 Children's Medical Center Corporation Short chain ceramide-based lipids and uses thereof
US11771771B2 (en) 2018-04-12 2023-10-03 Children's Medical Center Corporation Ceramide-like lipid-based delivery vehicles and uses thereof
CN109701009A (zh) * 2019-01-03 2019-05-03 华中师范大学 疫苗制剂及其应用
KR102146226B1 (ko) * 2019-03-07 2020-08-20 경희대학교 산학협력단 피토세라마이드 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 신경계 자가면역질환의 예방 또는 치료용 조성물
WO2022102557A1 (ja) * 2020-11-12 2022-05-19 国立研究開発法人理化学研究所 擬似糖脂質誘導体並びにその合成中間体、製造方法及び用途
EP4301374A4 (en) * 2021-03-01 2025-09-10 Deciduous Therapeutics Inc COMPOUNDS FOR ACTIVATING INVARIANT NATURAL KILLER T CELLS AND METHODS OF USE IN ELIMINATING INFLAMMATORY SENESCENT CELLS
WO2023096715A2 (en) * 2021-10-22 2023-06-01 President And Fellows Of Harvard College Immunomodulatory glycosphingolipids and methods of use thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5936076A (en) * 1991-08-29 1999-08-10 Kirin Beer Kabushiki Kaisha αgalactosylceramide derivatives
US5849716A (en) * 1992-10-22 1998-12-15 Kirin Beer Kabushiki Kaisha Sphingoglycolipids, their preparation, and therapeutic methods of use
US6238676B1 (en) * 1992-12-10 2001-05-29 Brigham And Women's Hospital Presentation of hydrophobic antigens to T-cells by CD1 molecules
US5853737A (en) * 1992-12-10 1998-12-29 Brigham And Women's Hospital Method for inducing a CD1-restricted immune response
US5679347A (en) * 1992-12-10 1997-10-21 Brigham And Women's Hospital Methods of isolating CD1-presented antigens, vaccines comprising CD1-presented antigens, and cell lines for use in said methods
ATE176237T1 (de) * 1993-04-15 1999-02-15 Kirin Brewery Sphingoglycolipid und verwendung davon
US5973128A (en) * 1996-11-22 1999-10-26 The Hospital For Sick Children Research And Development Lp Glycolipid mimics and methods of use thereof
JP2004131481A (ja) * 1997-04-10 2004-04-30 Kirin Brewery Co Ltd α−グリコシルセラミドを含有するＮＫＴ細胞活性化剤
ES2235324T3 (es) * 1997-04-10 2005-07-01 Kirin Beer Kabushiki Kaisha Empleo de a-glicosilceramidas para la obtencion de un agente terapeutico para enfermedades autoinmunes.
WO1999034209A1 (en) * 1997-12-31 1999-07-08 The Brigham And Women's Hospital, Inc. DIAGNOSTIC AND THERAPEUTIC METHODS BASED UPON Vα24JαQ T CELLS
WO2003009812A2 (en) * 2001-07-25 2003-02-06 New York University Use of glycosylceramides as adjuvants for vaccines against infections and cancer
EP1437358B1 (en) * 2001-08-16 2006-10-18 Daiichi Asubio Pharma Co., Ltd. Novel glycolipid and remedial agent for autoimmune disease containing the same as active ingredient
CA2493690C (en) * 2002-06-13 2011-11-08 New York University Synthetic c-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases
US20060116331A1 (en) * 2002-09-27 2006-06-01 Biomira, Inc. Glycosylceramide analogues
US7732583B2 (en) * 2003-02-14 2010-06-08 Japan As Represented By President Of National Center Of Neurology And Psychiatry Glycolipids and synthetic method thereof as well as their synthetic intermediates, and synthetic intermediates, and synthetic method thereof
EP1784196B1 (en) * 2004-08-27 2016-12-21 Albert Einstein College Of Medicine Of Yeshiva University Ceramide derivatives as modulators of immunity and autoimmunity

Similar Documents

Publication Publication Date Title
JP2008511634A5 (enExample)
ES2654382T3 (es) Método para la preparación de glucoesfingolípidos
JP6742403B2 (ja) アレナウイルス科およびコロナウイルス科のウイルス感染を処置するための方法
JP6905053B2 (ja) ベンジルフェニルエーテル誘導体、その調製方法、並びにその医薬組成物及び使用
JP2013541503A5 (enExample)
ES2865163T3 (es) Derivados de ácido oleanólico modificado en C4 para la inhibición de il-17 y otros usos
UA130059C2 (uk) ІНГІБУВАННЯ ІНТЕГРИНУ <font face="Symbol">a<sub></font>4</sub><font face="Symbol">b<sub></font>7</sub> ЛЮДИНИ
EP1619199A1 (en) Glycolipid derivatives, process for production of the same, intermediates for synthesis thereof, and process for production of the intermediates
TW401400B (en) Morphinan derivatives and medical uses thereof
EA018757B1 (ru) 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы
AU2025205450A1 (en) Bridged tricyclic carbamoylpyridone compounds and uses thereof
RU2012121813A (ru) Иммуноглобулины с двумя вариабельными доменами и их применение
JP2016501840A (ja) Ｅ−セレクチンアンタゴニスト化合物および使用方法
WO2014089269A1 (en) Compounds, compositions and methods using e-selectin antagonists for mobilization of hematopoietic cells
US20020032158A1 (en) Novel glycolipid derivatives
JP2010535210A5 (enExample)
CN114555077A (zh) 作为抗病毒剂的Patentiflorin A类似物
RU2009135016A (ru) Твердые формы, содержащие (-)-о-десметилвенлафаксин, и их применения
JP2015522702A (ja) 多量体マンノシド類、その製造方法および医薬としての使用
JP2009511599A5 (enExample)
KR20150022783A (ko) 신규 카르바메이트 당지질 및 그 용도
JPWO2019168999A5 (enExample)
ES2300877T3 (es) Derivados de esteroides glucosilados con actividad antimigratoria.
JP5126684B2 (ja) 新規糖脂質及びその用途
PT99659A (pt) Processo para preparacao de composicoes farmaceuticas com actividade imuno-supressora contendo xantinas